NewSpring Capital leads financing for cell therapy CDMO merger Kincellis
Published on September 17, 2026
Kincellis Advanced Therapies is a US-based contract development and manufacturing organization for cell and advanced-therapy modalities, operating roughly 140,000 square feet of GMP manufacturing space across Florida, North Carolina and Texas.
The post NewSpring Capital leads financing for cell therapy CDMO merger Kincellis appeared first on PE Hub.
